Exploring the Breadth of Stem Cell Science

It is a thrilling time for stem cell science. We have just seen FDA approval of two gene therapies for sickle cell disease and embryo models have been named the method of the year by Nature. As the field pushes forward with new achievements, the society is keeping pace with those advances, designing scientific programming to showcase new discoveries in stem cell research.

This month our community gathered in Vienna, Austria for Elucidating Principles of Development with Stem Cells, our last international symposium for 2023.  It was a fitting end to the year for us to position basic science research in developmental and cell biology front and center. From the picturesque surroundings of the Hofburg Palace, nearly 300 scientists from across biology disciplines representing 30 countries gathered to discuss how they leverage the latest stem cell technologies to understand the basic principles of embryogenesis.

In April, we will host the international symposium Stem Cells in Human Development and Disease in Cincinnati, USA, which will explore how developmental and stem cell biology intersect and bring translational efforts closer to clinical applications.

With tremendous thought, ISSCR’s scientific events offer our community an opportunity to become immersed in new research with researchers who share similar interests. The international symposia programs complement the 2024 annual meeting program, which will be the most clinically focused annual meeting in the society’s history.

In 2024, the annual meeting will be back in Europe for the first time since 2015. I invite you to make plans to join us in Germany 10-13 July and to consider submitting your abstract to take advantage of the unmatched opportunity to present your work and gather feedback and insights from our global research community.

I look forward to seeing you in Hamburg and learning more about what research questions you are seeking to answer and what drives your curiosity.

Previous
Previous

Fish-like Genetic Program Used to Turn Human Retinal Cells Into Neurons

Next
Next

Member Spotlight: Mingxia Gu, MD, PhD